Serum tears, a promising treatment for severe dry eye disease, harness the healing power of natural proteins and growth factors. Both autologous and allogeneic options are available to restore comfort and ocular health.
Dry eye disease (DED) is a chronic condition in which the eyes either do not produce enough tears or the quality of the tears is compromised. When standard treatments such as artificial tears fail to provide the relief patients need, serum tears offer a natural, biologic alternative. In this article, our eye doctors explain how both autologous (from your own blood) and allogeneic (from a donor’s blood) serum tears work and why they could be the answer for severe, refractory dry eye.
Tears are more than just water; they are a complex mixture of proteins, vitamins, growth factors, and other nutrients that are essential for maintaining the health of the ocular surface. Autologous serum tears (ASTs) are made from a patient’s own blood, which is processed to isolate the serum that shares many components with natural tears. Allogeneic serum tears, by contrast, come from a carefully screened donor and provide an alternative for patients who cannot safely donate their own blood.
These serum tears have shown notable benefits in patients suffering from severe dry eye conditions, including those associated with autoimmune disorders like Sjögren’s syndrome, rheumatoid arthritis, and other ocular surface diseases. By supplying essential nutrients missing in conventional artificial tears, serum tears aim to restore the ocular surface, promote healing, and reduce inflammation.
The concept behind autologous serum tears is based on the fact that the blood serum contains growth factors, proteins, vitamins, and enzymes similar to those found in natural tears. When artificial tears are no longer sufficient to manage symptoms, drawing on one’s own serum can provide a tailored, biocompatible treatment that facilitates regeneration of the ocular surface.
Here’s the process our eye doctors use:
Because autologous serum tears are derived from a patient’s own blood, they are highly biocompatible and carry a minimal risk of immune rejection or adverse reactions. This makes them an attractive option for those with the most severe forms of dry eye.
Contact our team to schedule a consultation and find out if serum tears are the right choice for your dry eye treatment.
Not every patient is a candidate for autologous serum tear production. Some patients may have poor venous access, low hemoglobin levels, or systemic conditions that make repeated blood draws unsafe or unfeasible. This is where allogeneic serum tears come in handy.
Allogeneic serum tears are made from the blood of a carefully screened donor, typically one whose blood type is compatible with the patient’s own (often from a donor with type AB, known as the universal plasma donor). The preparation process for allogeneic serum tears mirrors that of autologous drops, ensuring that the final product contains similar concentrations of growth factors, proteins, and healing agents.
The advantages of allogeneic serum tears include:
Both autologous and allogeneic serum tears have shown comparable efficacy in improving tear film stability, reducing inflammation, and promoting corneal healing. This makes them an attractive second-line or even early treatment alternative for patients with inflammatory ocular surface disease that does not respond well to standard therapies.
The effectiveness of serum tears lies in their rich composition:
By mimicking the natural composition of tears, serum tears help restore the ocular surface to a more natural and healthy state. This not only improves patient comfort but also enhances the overall stability of the tear film, leading to lasting improvements in vision quality and eye comfort.
Contact our team to schedule a consultation and find out if serum tears are the right choice for your dry eye treatment.
Serum tears, both autologous and allogeneic, provide effective relief for severe dry eye disease when traditional treatments fail.